Ahmaddy, F.; Burgard, C.; Beyer, L.; Koehler, V.F.; Bartenstein, P.; Fabritius, M.P.; Geyer, T.; Wenter, V.; Ilhan, H.; Spitzweg, C.;
et al. 18F-FDG-PET/CT in Patients with Advanced, Radioiodine Refractory Thyroid Cancer Treated with Lenvatinib. Cancers 2021, 13, 317.
https://doi.org/10.3390/cancers13020317
AMA Style
Ahmaddy F, Burgard C, Beyer L, Koehler VF, Bartenstein P, Fabritius MP, Geyer T, Wenter V, Ilhan H, Spitzweg C,
et al. 18F-FDG-PET/CT in Patients with Advanced, Radioiodine Refractory Thyroid Cancer Treated with Lenvatinib. Cancers. 2021; 13(2):317.
https://doi.org/10.3390/cancers13020317
Chicago/Turabian Style
Ahmaddy, Freba, Caroline Burgard, Leonie Beyer, Viktoria Florentine Koehler, Peter Bartenstein, Matthias P. Fabritius, Thomas Geyer, Vera Wenter, Harun Ilhan, Christine Spitzweg,
and et al. 2021. "18F-FDG-PET/CT in Patients with Advanced, Radioiodine Refractory Thyroid Cancer Treated with Lenvatinib" Cancers 13, no. 2: 317.
https://doi.org/10.3390/cancers13020317
APA Style
Ahmaddy, F., Burgard, C., Beyer, L., Koehler, V. F., Bartenstein, P., Fabritius, M. P., Geyer, T., Wenter, V., Ilhan, H., Spitzweg, C., & Todica, A.
(2021). 18F-FDG-PET/CT in Patients with Advanced, Radioiodine Refractory Thyroid Cancer Treated with Lenvatinib. Cancers, 13(2), 317.
https://doi.org/10.3390/cancers13020317